c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

BACKGROUND: KIT inhibitors, such as toceranib (TOC), and vinblastine (VBL) have not been prospectively compared in the treatment of macroscopic mast cell tumors (MCTs). Also, it is unknown whether VBL or TOC is superior for treating MCT without c‐kit mutations. HYPOTHESIS/OBJECTIVES: To determine th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Vet Intern Med
Main Authors: Weishaar, K.M., Ehrhart, E.J., Avery, A.C., Charles, J.B., Elmslie, R.E., Vail, D.M., London, C.A., Clifford, C.A., Eickhoff, J.C., Thamm, D.H.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
SMALL ANIMAL
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5787208/
https://ncbi.nlm.nih.gov/pubmed/29194765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.14889
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados